Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.1K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.1K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

5.4K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.4K
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

3.0K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
3.0K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

421
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
421
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

2.6K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.6K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

4.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Client Participation per Round in Federated Learning for Multiple Sclerosis with Real-World Data.

Studies in health technology and informatics·2026
Same author

Good for All, Not Good Enough for One: Reuse Dilemma in Federated Learning.

Studies in health technology and informatics·2026
Same author

On the state of protein function prediction: a report on the fourth CAFA challenge.

bioRxiv : the preprint server for biology·2026
Same author

Extracellular Vesicle-Associated miR-222-3p and miR-186-5p as Potential Hypoxic Markers in Canine Osteosarcoma: A Preliminary In Vitro Study.

Animals : an open access journal from MDPI·2026
Same author

A Comparative Study of QSPR Methods on a Unique Multitask PAMPA Data Set.

Journal of chemical information and modeling·2026
Same author

WiNGS-API: a federated genome/phenome data sharing platform enabling gene discovery and variant classification for rare diseases.

Genome medicine·2026

Related Experiment Video

Updated: Jul 28, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K

Nonlinear data fusion over Entity-Relation graphs for Drug-Target Interaction prediction.

Eugenio Mazzone1, Yves Moreau2, Piero Fariselli1

  • 1Department of Medical Sciences, University of Torino, 10123 Torino, Italy.

Bioinformatics (Oxford, England)
|May 31, 2023
PubMed
Summary

This study introduces a novel data fusion approach for predicting Drug-Target Interactions (DTIs), outperforming existing methods. The approach offers flexibility in predicting both binary classifications and real-valued affinities, enhancing drug design and repurposing efforts.

More Related Videos

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.7K
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.7K

Related Experiment Videos

Last Updated: Jul 28, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.7K
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.7K

Area of Science:

  • Computational chemistry
  • Bioinformatics
  • Machine learning

Background:

  • Predicting Drug-Target Interactions (DTIs) is crucial for drug design and repurposing.
  • Existing methods often lack flexibility or require stricter validation.

Purpose of the Study:

  • To present a novel data fusion approach for DTI prediction using the NXTfusion library.
  • To generalize Matrix Factorization for nonlinear inference over Entity-Relation graphs.

Main Methods:

  • Developed a data fusion approach for DTI prediction.
  • Extended Matrix Factorization to nonlinear inference on Entity-Relation graphs using NXTfusion.
  • Benchmarked against state-of-the-art methods on five datasets.

Main Results:

  • The proposed models outperformed existing methods on DTI prediction tasks.
  • The approach demonstrated flexibility in predicting both binary DTIs and real-valued drug-target affinity.
  • Findings suggest stricter validation for DTI methods in realistic settings.

Conclusions:

  • The Entity-Relation data fusion approach effectively integrates heterogeneous information for DTI prediction.
  • The method offers a flexible and high-performing solution for computer-aided drug design.
  • Stricter validation mimicking real-world scenarios is recommended for DTI prediction methods.